Literature DB >> 6446389

Antimicrobial activity and spectrum of cefoperazone against recent clinical isolates.

R N Jones, P C Fuchs, A L Barry, T L Gavan, E H Gerlach, H M Sommers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6446389

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


× No keyword cloud information.
  8 in total

1.  Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.

Authors:  V I Ahonkhai; C E Cherubin; M A Shulman; U Bancroft
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

2.  Cefoperazone pharmacokinetics in preterm infants.

Authors:  J A Bosso; G M Chan; J M Matsen
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

3.  Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis.

Authors:  D Cable; G Overturf; G Edralin
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

4.  Penetration and clearance of cefoperazone and moxalactam in pleural fluid.

Authors:  H Yamada; T Iwanaga; H Nakanishi; M Yamaguchi; K Iida
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

5.  Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.

Authors:  M W Drulak; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

6.  Tentative interpretive standards for agar disk diffusion antimicrobial susceptibility testing of cefoperazone.

Authors:  C Thornsberry; A L Barry; R N Jones; C N Baker; R E Badal
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

Review 7.  Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; A Carmine; R C Heel; P A Morley; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-12       Impact factor: 9.546

8.  Cefoperazone: spectrum of antibacterial activity and disc diffusion testing.

Authors:  C Thornsberry; R N Jones
Journal:  Drugs       Date:  1981       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.